The use of molecular biology in diagnosis and prognosis of gastric cancer.

doi:10.1016/s0960-7404(00)00016-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The use of molecular biology in diagnosis and prognosis of gastric cancer.

Surgical oncology - 1 Jul 2000

Becker K F, Keller G, Hoefler H

Abstract excerpt

The investigation of molecular and genetic changes in gastric cancer has brought new insights into the pathogenesis of the disease. Knowledge of the genetic abnormalities and altered molecules could be used for differential diagnosis in case of an unknown primary tumor, allows their evaluation as prognostic factors, and could open novel avenues for more specific clinical interventions. Clinically relevant...

Topics

Apoptosis
Biomarkers, Tumor
Cell Adhesion Molecules
Cytokines
Gene Amplification
Gene Expression Regulation, Neoplastic
Genes, Tumor Suppressor
Genetic Predisposition to Disease
Genetic Testing
Genetic Variation
Growth Substances
Humans
Molecular Biology
Prognosis
Receptor Protein-Tyrosine Kinases
Risk Assessment
Risk Factors
Stomach Neoplasms

Source

Open in PubMed

Identifiers

PMID: 11525306
DOI: 10.1016/s0960-7404(00)00016-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics